Further experiments conducted on obese children (median age 10) corroborated these findings, indicating a significant elevation of Hsp90β levels when compared to Hsp90α levels, particularly upon transitioning from non‐NAFLD to NAFLD cases. Here, HSP90AB1 is linked to metabolic dysfunction-associated steatotic liver disease.